Device/Pharma Companies Leverage Digital Tools To Monitor Medication Adherence
Executive Summary
Digital health tools, pharmaceuticals and medical devices are converging in new wireless technologies designed to remotely monitor patient medication-taking behavior and to measure physiological responses to some drugs. Companies say these connected devices and services will help improve medication adherence and patient outcomes, and will save the health care system billions of dollars by preventing unnecessary doctor's visits and hospital admissions.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.